BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BAHM - ECPv6.17.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://bahm-alliance.org
X-WR-CALDESC:Events for BAHM
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20210314T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20211107T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20220313T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20221106T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20230312T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20231105T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20220517T120000
DTEND;TZID=America/Chicago:20220517T130000
DTSTAMP:20220427T215338Z
CREATED:20220427T215338Z
LAST-MODIFIED:20220427T215338Z
UID:7021-1652788800-1652792400@bahm-alliance.org
SUMMARY:340B Program Perspectives: Insight on Current Contract Pharmacy Issues
DESCRIPTION:The federal 340B drug discount program provides certain providers with deep discounts on some outpatient drugs. Last year the 340B program saw substantial growth amidst uncertainty related to the use of contract pharmacies. The health care data and analytics firm\, IQVIA\, reported that in 2021\, 340B program sales reached $93.6 billion and grew 15.9% year-on-year. However\, last year more pharmaceutical manufacturers announced or implemented a change to not offer the 340B discount to drugs dispensed under contract pharmacy arrangements in certain cases. The growth\, policy\, and legal issues of the 340B program are significant not only to impacted health care providers and pharmaceutical manufacturers\, but also to other stakeholders such as health plans\, data vendors\, and even Congress. \nThis virtual symposium hosted by the Business Advancement Center for Health (BACH) in partnership with Leavitt Partners\, will review the latest legal and policy questions under discussion in the Courts and Congress and explain how impacted stakeholders are responding to the ever-evolving 340B program landscape.
URL:https://bahm-alliance.org/event/340b-program-perspectives-insight-on-current-contract-pharmacy-issues/
LOCATION:Online
END:VEVENT
END:VCALENDAR